| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $150.9M | +49.4% | +31.0% |
| R&D Expense | $13.2M | +27.2% | +27.8% |
| SG&A Expense | $79.7M | +8.0% | +11.1% |
| Operating Income | $20.7M | +264.8% | +232.1% |
| Pre-tax Income | $21.2M | +278.8% | +263.4% |
| Income Tax | -$407K | +83.3% | +93.7% |
| Net Income | $21.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $63.7M | -12.8% | -32.4% |
| Accounts Receivable | $168.8M | +40.2% | +66.7% |
| Inventory | $39.6M | +19.8% | +46.4% |
| Current Assets | $299.7M | +15.2% | +25.7% |
| Total Assets | $509.8M | +10.6% | +14.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$49.7M | — | — |
| Capital Expenditures | $9.5M | — | — |
| Investing Cash Flow | -$9.5M | — | — |
| Financing Cash Flow | -$12.6M | — | — |
| Free Cash Flow | -$59.2M | — | — |
| +329.6% |
| +74.9% |
| EPS (Basic) | $0.11 | +210.0% | +22.2% |
| EPS (Diluted) | $0.11 | +210.0% | +22.2% |
| $90.3M |
| +37.2% |
| +16.9% |
| Total Liabilities | $123.8M | +24.0% | -26.2% |
| Stockholders' Equity | $255.1M | +9.4% | -8.4% |